Ecofuril® suspension 90 ml
Description
Helps combat diarrhea:
- Acts only within the intestinal lumen, without systemic effects on the body
- Starts working after the first dose
- Eliminates the cause of diarrhea – pathogenic bacteria and reduces toxin production
- Included in treatment standards
Promotes restoration of microflora:
- Does not affect beneficial microflora
- Prevents the development of bacterial complications in viral diarrhea
- Restores gut eubiosis
- Does not require additional courses of pro- and prebiotics during the recovery period.
Ecofuril suspension is convenient to use:
- Banana flavor - easy to give to children.
- Ready for use - no need for complex calculations or additional steps.
- Includes a dosing spoon - easy to dose and hard to make a dosing mistake.
Dosage Form and Composition
Oral suspension 90 ml in a dark glass bottle with a dosing spoon.
5 ml of suspension contains:
Active substance: nifuroxazide 200.00 mg
Indications for Use
Acute bacterial diarrhea, occurring without worsening of general condition, fever, or intoxication.
Dosage and Administration
Orally.
Shake the suspension well before use.
A double-sided measuring spoon, with a volume of 2.5 ml on one side and 5 ml on the other, is used for dosing.
Children aged 1-6 months: 2.5 ml 2 or 3 times a day.
Children aged from 6 months to 3 years: 2.5 ml 3 times a day.
Children aged from 3 to 6 years: 5 ml 3 times a day.
Children aged from 6 to 18 years: 5 ml 3-4 times a day.
Adults: 5 ml 4 times a day.
The duration of the treatment course is 5-7 days.
Pharmacy Supply Terms
By prescription
See also:
Our certificates:
Instructions for Use of Ecofuril® suspension 90 ml
Registration Number: LP-004631
Trade Name: Ecofuril®
International Nonproprietary or Grouping Name: nifuroxazide
Dosage Form: oral suspension
Composition
5 ml of suspension contain:
Active substance: nifuroxazide 200.00 mg;
Excipients: maltitol – 350.00 mg, povidone K-90 – 25.00 mg, xanthan gum – 20.00 mg, banana flavor – 10.00 mg, methylparaben – 5.00 mg, sodium citrate dihydrate – 0.015 mg, anhydrous citric acid – 0.001 mg, purified water – up to a suspension volume of 5.0 ml.
Description
A homogeneous yellow suspension with a characteristic odor.
Pharmacotherapeutic Group Antimicrobial agent - nitrofuran.
ATC Code: A07AX03
Pharmacological Properties
An antimicrobial agent, a nitrofuran derivative. It blocks dehydrogenase activity and inhibits the respiratory chain, the tricarboxylic acid cycle, and a number of other biochemical processes in the microbial cell. It disrupts the microbial cell membrane and reduces toxin production by microorganisms. Highly active against Campylobacter jejuni, Escherichia coli, Salmonella spp., Shigella spp., Clostridium perfringens, Vibrio cholerae, pathogenic Vibrios and Vibrio parahaemolyticus, Staphylococcus spp.
Weakly sensitive to nifuroxazide: Citrobacter spp., Enterobacter cloacae and Proteus indologenes. Resistant to nifuroxazide: Klebsiella spp., Proteus mirabilis, Providencia spp., Pseudomonas spp.
Does not disrupt the balance of intestinal microflora. In acute bacterial diarrhea, it restores gut eubiosis. In case of infection with enterotropic viruses, it prevents the development of bacterial superinfection.
Pharmacokinetics
After oral administration, nifuroxazide is practically not absorbed from the digestive tract and exerts its antibacterial action exclusively in the intestinal lumen. Nifuroxazide is excreted via the intestines: 20% unchanged, and the remaining amount – chemically altered.
Indications for Use
Acute bacterial diarrhea, occurring without worsening of general condition, fever, or signs of intoxication.
Contraindications
- hypersensitivity to nifuroxazide, to nitrofuran derivatives, other components of the drug,
- pregnancy,
- neonatal period (up to 1 month), prematurity.
With caution
- liver disease,
- alcoholism,
- traumatic brain injury,
- brain diseases,
- lactation period,
- children over 1 month of age.
Use During Pregnancy and Breastfeeding
The use of the drug during pregnancy is contraindicated. Before using the drug during breastfeeding, consult your doctor.
Dosage and Administration
Orally. A double-sided measuring spoon, with a volume of 2.5 ml on one side and 5 ml on the other, is used for dosing. Shake the suspension well before use.
Children aged 1-6 months: 2.5 ml 2 or 3 times a day (at 8-12 hour intervals).
Children aged from 6 months to 3 years: 2.5 ml 3 times a day (8-hour intervals between doses).
Children aged from 3 to 6 years: 5 ml 3 times a day (8-hour intervals between doses). Children aged from 6 to 18 years: 5 ml 3-4 times a day (6-8 hour intervals between doses).
Adults: 5 ml 4 times a day (6-hour intervals between doses).
The duration of the treatment course is 5-7 days, but not more than 7 days. If no improvement is seen within the first three days, consult a doctor. Use the drug according to the dosage and administration method specified in the instructions. If necessary, consult a doctor before using the drug.
Side Effects
Allergic reactions (skin rash, urticaria, angioedema, anaphylactic shock). If any of the side effects listed in the instructions worsen, or you notice any other side effects not listed, inform your doctor.
Overdose
Symptoms of overdose are unknown. Symptomatic treatment is recommended.
Drug Interactions
Concomitant use with drugs causing disulfiram-like reactions or those inhibiting the function of the central nervous system is not recommended. If you are taking other drugs (including over-the-counter ones), consult your doctor before using nifuroxazide.
Special Precautions
When treating diarrhea, rehydration therapy should be conducted simultaneously with nifuroxazide therapy. Treatment of diarrhea in children under 3 years of age should be carried out under medical supervision. In case of bacterial diarrhea with signs of systemic involvement (worsening of general condition, fever, symptoms of intoxication or infection), consult a doctor to decide on the use of systemic antibacterial drugs.
If symptoms of a hypersensitivity reaction occur (skin rash and itching, difficulty breathing, shortness of breath), discontinue the drug.
Due to the content of methylparaben, the drug may cause allergic reactions (possibly delayed).
Alcohol consumption is prohibited during nifuroxazide therapy.
Effect on Ability to Drive Vehicles and Operate Machinery
The drug does not negatively affect the ability to drive vehicles and/or operate machinery.
Packaging
Oral suspension 200 mg/5 ml.
90 ml in a 100 ml dark glass bottle with a screw-on plastic cap.
Each bottle, together with a double-sided measuring spoon (small capacity 2.5 ml, large – 5 ml) and instructions for use, is placed in a cardboard carton.
Storage Conditions
Store in a place protected from light at a temperature not exceeding 25 °C. Do not freeze. The opened bottle should be stored for no more than 7 days. Keep out of reach of children.
Shelf Life
2 years. Do not use after the expiration date.
Supply Terms
Over-the-counter.
Name and Address of the Legal Entity in whose name the Marketing Authorization is issued / Organization handling complaints:
JSC "AVVA RUS", Russia, 121614,
Moscow, ul. Krylatskie Kholmy, 30, bld. 9. Tel.: +7 (495) 956-75-54.
avva.com.ru ecofuril.ru
Manufacturing Site Address:
JSC "AVVA RUS", Russia, 610044, Kirov region, Kirov, ul. Luganskaya, 53a.
Tel.: +7 (8332) 25-12-29; +7 (495) 956-75-54.
